top of page
Discover
The Latest From Our PRN Community
Welcome to our blog by PRN members for PRN members, filled with unique and engaging content to explore, connect, and engage with the world of ambulatory care pharmacy!

Search


New Kid on the Block - Retatrutide for Obesity Management
Written by Mariana Lopez, PharmD Candidate 2026 and Adenike Atanda-Oshikoya PharmD, BCACP, CDCES, CTTS Background on Obesity and Comorbidities Obesity, as defined by the World Health Organization (WHO), is the excessive and unhealthy accumulation of body fat.(1) Severe obesity is strongly associated with comorbid conditions such as type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), heart failure, chronic liver disease, and reduced life expectancy.(2) In addition t
Dec 10, 20256 min read


Pediatric RSV Prevention Gets an Upgrade in Nirsevimab
Written by Ardis M. Copenhaver, PharmD, MS, BCPS Respiratory syncytial virus (RSV) is a respiratory virus that usually causes cold-like symptoms and tends to occur between the beginning of October and end of March in the United States.(1) It is the most common cause of lower respiratory tract infections in children younger than 1 year of age and the leading cause of hospitalization among infants.(1) The highest rate of hospitalizations occurs during the first months of life w
Sep 19, 20254 min read


Relieving the Pressure: Pulmonary Arterial Hypertension Treatment Review and Updates
Written by Kellie Ball, PharmD, MPH, BCACP and Danielle Dennis, PharmD, BCPS What is Pulmonary Hypertension (PH)? PH is a complex, often fatal condition characterized by abnormally high pressures in the pulmonary arteries caused in large part by smooth muscle and endothelial cell proliferation.(1) If left untreated, these complex and multifactorial processes may lead to right ventricle dysfunction, heart failure, and death.(2) PH describes a group of disorders that fall int
Dec 19, 20245 min read


The Role of GLP-1 Receptor Agonists in Patients with Type 2 Diabetes and Diabetic Kidney Disease – Overview and Updates
By Andrea Lenear, PharmD Candidate 2025 and Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES What is Diabetic Kidney Disease? Chronic kidney...
Jul 22, 20246 min read


Advancement in Technology: SmartWatch
By Devon Hess, MBA, PharmD Candidate 2024 and Rachel Long, PharmD, BCPS, CPP, CDCES Advancements in technology have revolutionized...
Nov 6, 20234 min read


Are You Up for the Challenge? Updates on Beta-Lactam Allergies
By Kayla C. Godfrey, PharmD and Deanna McDanel, PharmD, BCPS, BCACP Introduction Penicillin allergies are reported by approximately 10%...
Oct 15, 20234 min read


Empagliflozin in Patients with Chronic Kidney Disease - EMPA-KIDNEY 2023
By Reham Awad, PharmD, BCPS and Mukti Patel, PharmD Background Sodium-glucose cotransporter 2 inhibitors (SGLT2i) were originally...
Sep 24, 20234 min read


Changes in AHA/ACC/HFSA Guideline for Management for Heart Failure
By Jiya Thomas, PharmD and Adenike Atanda, PharmD, BCACP, CDCES, CTTS Introduction The AHA/ACC/HFSA guideline for the management of heart...
Jul 7, 20233 min read


Tackling Type 2 Diabetes Mellitus: 2023 ADA Pharmacologic Approaches to Glycemic Treatment Updates
By Justin Ramnarain, PharmD; Claudette Donatien, PharmD; Sami Barakat, PharmD; Rebecca Khaimova, PharmD, BCACP, CDCES Introduction In...
Mar 30, 20235 min read


Nonstatins and New Goals – 2022 ACC Expert Consensus Decision Pathway Cholesterol Updates
By Kathryn Litten, PharmD, BCACP and Oluwaseun Awofisayo, PharmD Candidate 2023 Introduction In October 2022, the American College of...
Mar 14, 20233 min read


Topical Therapies for Psoriasis: Where do we start, and what's new?
By Zach Krauss, PharmD Candidate 2023; Juanita A. Draime, PharmD Introduction Psoriasis vulgaris is an inflammatory skin condition that...
Oct 3, 20227 min read


Pearls from the ADA 2022 Updates on Standards of Medical Care in Diabetes
By Da Som Kim, PharmD; Kathleen Horan, PharmD; Rebecca Khaimova, PharmD, BCACP Diabetes is a chronic and progressive disease...
Apr 28, 20224 min read


ISTH Direct Oral Anticoagulant (DOAC) Update for Use in Venous Thromboembolism in Obesity
By Jason Chau, PharmD; Holly Flynn, PharmD; Sarah Greiner, PharmD; Stephanie Hendricks, PharmD According to the Centers for Disease...
Mar 27, 20227 min read
bottom of page